Knowledge

Clinical descriptions of ME/CFS

Source 📝

22: 57: 509:" (PENE), which encompasses fatigability, symptoms worsening after exertion, exhaustion after exertion, a prolonged recovery from activity, and reduction of activities due to symptoms. The ICC definition describes severity levels: Mild ME is described as roughly a 50% in functioning compared to before the illness, moderate ME makes one mostly housebound, severe refers to mostly bed-bound, and a very severe being completely bed-bound and requiring care from others. 1289:
Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisbik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall
636:
The National Institute for Health and Clinical Excellence (NICE) in England and Wales that in the absence of a biomarker, it is difficult to say one set of criteria is more valid than another. The quality can be assessed based on how the case definition was created. In particular, to what extend it
344:
The Oxford criteria differ from the Fukuda criteria in that mental fatigue is required and that symptoms that could be psychiatric in origin can count toward a diagnosis. Likewise, the Oxford criteria differs from the Canadian consensus criteria by not excluding patients who may have a psychiatric
649:
An examination of the CDC 1994 criteria applied to several hundred patients found that the diagnosis could be strengthened by adding two new symptoms (anorexia and nausea) and eliminating three others (muscle weakness, joint pain, sleep disturbance). Other suggested improvements to the diagnostic
222:
A mental status examination to identify abnormalities in mood, intellectual function, memory, and personality. Particular attention should be directed toward current symptoms of depression or anxiety, self-destructive thoughts, and observable signs such as psychomotor retardation. Evidence of a
47:
is poorly understood, and it can be a difficult condition to diagnose because there is no standard test, many symptoms are non-specific, and because doctors and patients may be unfamiliar with post-exertional malaise. Subgroup analysis suggests that, depending on the applied definition, CFS may
394:
Unlike some criteria, the Canadian consensus criteria exclude patients with symptoms of mental illness. This definition was updated in 2010 to provide greater specification to the original. Functional impairment must be below defined thresholds in two of the three designated subscales of the
229:
A minimum battery of laboratory screening tests, including complete blood count with leukocyte differential; erythrocyte sedimentation rate; serum levels of alanine aminotransferase, total protein, albumin, globulin, alkaline phosphatase, calcium, phosphorus, glucose, blood urea nitrogen,
218:
A thorough history that covers medical and psychosocial circumstances at the onset of fatigue; depression or other psychiatric disorders; episodes of medically unexplained symptoms; alcohol or other substance abuse; and current use of prescription and over-the-counter medications and food
546:
The CDC states that diagnostic tests should be directed to confirm or exclude other causes for fatigue and other symptoms. Further tests may be individually necessary to identify underlying or contributing conditions that require treatment. The following routine tests are recommended:
425:
These symptoms must have lasted at least 6 months. The London criteria also mention that other symptoms, including autonomic and immune symptoms, are common and may help confirm a diagnosis. In light of the advances in understanding of ME and CFS, the criteria for ME as described by
645:
A 2003 international CFS study group for the CDC found ambiguities in the CDC 1994 CFS research case definition which contribute to inconsistent case identification. Different self-reported causes of CFS are associated with significant differences in clinical measures and outcomes.
317:
The Oxford criteria were published in 1991 and include both CFS of unknown etiology and a subtype of CFS called post-infectious fatigue syndrome (PIFS), which "either follows an infection or is associated with a current infection." The Oxford criteria defines CFS as follows:
439:
The International Consensus Criteria were based on the Canadian consensus criteria and developed by a group of 26 individuals from 13 countries and consisting of clinicians, researchers, teaching faculty, and an independent patient advocate. The ICC define the illness as:
517:
Several countries, including Australia and the United Kingdom, have authored clinical guidelines that define ME/CFS based on some or all of the available diagnostic criteria. The 2021 UK NICE guideline requires all of the following symptoms:
1493:
Kennedy G, Abbot NC, Spence V, Underwood C, Belch JJ (February 2004). "The specificity of the CDC-1994 criteria for chronic fatigue syndrome: comparison of health status in three groups of patients who fulfill the criteria".
100:
They also note that for all symptoms except orthostatic intolerance, "frequency and severity of symptoms should be assessed," and that these symptoms should be present at least half the time with at least moderate severity.
924:
Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, Komaroff A (15 December 1994). "The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group".
658:
A new "empirical definition" of the CDC 1994 criteria was published in 2005. A 2009 evaluation of the 2005 empirical definition compared 27 patients with a prior diagnosis of CFS with 37 patients diagnosed with a
430:
and others were updated in 2009. These have been cited in articles and are being evaluated as of 2011, for example, in studies to ascertain differences between patients selected using different case definitions.
147:
The concurrent occurrence of four or more of the following symptoms, all of which must have persisted or recurred during six or more consecutive months of illness and must not have predated the fatigue:
411:
in all studies they funded until the mid-1990s. An incomplete version edited by Nick Anderson (CEO of AFME) was published in a 1994 report. The London criteria require the following:
808:
Jason LA, Taylor RR, Kennedy CL, Song S, Johnson D, Torres S (September 2000). "Chronic fatigue syndrome: occupation, medical utilization, and subtypes in a community-based sample".
113:. The criteria were described as the most widely used diagnostic criteria for CFS in 2007. These criteria are sometimes called the "Fukuda definition" after the first author ( 1617:
Reeves, William; Dieter Wagner; Rosane Nisenbaum; James Jones; Brian Gurbaxani; Laura Solomon; Dimitris Papanicolaou; Elizabeth Unger; Suzanne Vernon; Christine Heim (2005).
1676:
Jason, Leonard A; Najar, Natasha; Porter, Nicole; Reh, Christy (2009). "Evaluating the Centers for Disease Control's Empirical Chronic Fatigue Syndrome Case Definition".
1880: 211:
All other known causes of chronic fatigue must have been ruled out, specifically clinical depression, side effects of medication, eating disorders and substance abuse.
44: 663:. The researchers reported that "38% of those with a diagnosis of a Major Depressive Disorder were misclassified as having CFS using the new CDC definition." 505:
Compared to the Canadian criteria, chronic fatigue is not required, and there is no requirement for symptoms to occur for 6 months. The main symptom is "
1398:
Identifying and diagnosing ME/CFS: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review D
1747: 1738: 246:
The initial chronic fatigue syndrome definition was published in 1988. It is also called the "Holmes definition", after the manuscript's first author.
33: 36:) vary. Different groups have produced sets of diagnostic criteria that share many similarities. The biggest differences between criteria are whether 73:
criteria come from the IOM's 2015 report on CFS, and the CDC currently uses this definition. The IOM criteria require the following three symptoms:
683:"Understanding History of Case Definitions and Criteria | Healthcare Providers | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC" 234:
Other diagnostic tests have no recognized value unless indicated on an individual basis to confirm or exclude a differential diagnosis, such as
543:
As there is no generally accepted test for chronic fatigue syndrome, diagnosis is based on symptoms, history, and ruling out other conditions.
1529:
Komaroff AL; Fagioli LR; Geiger AM; et al. (January 1996). "An examination of the working case definition of chronic fatigue syndrome".
1239:"Contrasting case definitions for chronic fatigue syndrome, myalgic encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitis" 309:
To make a diagnosis, a patient must meet either 8 of the 11 symptom criteria, or 6 of the 11 symptom criteria and 2 of 3 physical criteria.
535:
Additionally, the symptoms must be present for at least 6 weeks in adults and 4 weeks in children, and not explained by another condition.
110: 1354:"Recommendations | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | Guidance | NICE" 1062: 844:"IOM 2015 Diagnostic Criteria | Diagnosis | Healthcare Providers | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC" 1444:"Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution" 1731: 506: 1215: 843: 502:
The ICC definition also notes that children may have somewhat different symptoms, and that symptoms tend to be more variable.
1406: 882: 223:
psychiatric or neurologic disorder requires that an appropriate psychiatric, psychological, or neurologic evaluation be done;
160:
severe enough to cause substantial reduction in previous levels of occupational, educational, social, or personal activities;
898: 1420: 1148: 1724: 1149:"Myalgic encephalomyalitis/chronic fatigue syndrome: Clinical working definition, diagnostic and treatment protocols" 464:
Immune, gastrointestinal and genitourinary symptoms: patients must have at least one symptom in three of five areas:
1564:
King C, Jason LA (February 2005). "Improving the diagnostic criteria and procedures for chronic fatigue syndrome".
109:
The 1994 research guidelines were proposed by the "International Chronic Fatigue Syndrome Study Group", led by the
1353: 1813: 1025:
Holmes GP; Kaplan JE; Gantz NM; et al. (March 1988). "Chronic fatigue syndrome: a working case definition".
682: 138:
results in substantial reduction in previous levels of occupational, educational, social, or personal activities.
580: 1859: 357:
and published by an international group of researchers in 2003. The requirements are summarized as follows:
869: 70: 1818: 1401:. NICE Evidence Reviews Collection. London: National Institute for Health and Care Excellence (NICE). 1716: 1338: 660: 637:
represented a consensus process and involved stakeholders such as patients, doctors and researchers.
1690: 1578: 1849: 1854: 1771: 1059: 94: 37: 1189: 1685: 1573: 1381: 484:
Energy production symptom: patients must have at least one symptom from any of the four lists
938: 625: 575: 1124: 331:
The fatigue must have lasted for 6 months or longer, and be present at least 50% of the time
551: 447:
Neurological symptoms: patients must have at least one symptom from one of the four lists:
230:
electrolytes, and creatinine; determination of thyroid-stimulating hormone; and urinalysis.
117:) of the publication. The 1994 CDC criteria specify the following conditions must be met: 8: 606: 21: 1619:"Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study" 337:
Conditions known to cause severe fatigue and some mental conditions exclude a diagnosis.
1703: 1653: 1618: 1599: 1316: 1291: 1263: 1238: 1107: 1082: 1050: 1004: 950: 790: 744: 709: 584: 235: 1542: 1470: 1443: 253:
Debilitating fatigue of new onset which interferes with the patient's daily activities
1808: 1658: 1640: 1591: 1546: 1511: 1475: 1412: 1402: 1321: 1307: 1268: 1112: 1042: 996: 991: 974: 942: 878: 825: 821: 782: 731: 334:
Other symptoms are possible, such as muscle pain, mood problems, or sleep disturbance
153: 1707: 1603: 1587: 1507: 1054: 1008: 125:
Clinically evaluated, unexplained, persistent or relapsing chronic fatigue that is:
1766: 1695: 1648: 1630: 1583: 1538: 1503: 1465: 1455: 1311: 1303: 1258: 1250: 1223: 1163: 1102: 1094: 1034: 986: 934: 817: 794: 772: 739: 721: 954: 1066: 902: 592: 1038: 871:
Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness
1844: 1839: 1396: 1098: 726: 565: 1616: 777: 760: 708:
Davis, Hannah E.; McCorkell, Lisa; Vogel, Julia Moore; Topol, Eric J. (2023).
341:
Post-infectious fatigue syndrome also requires evidence of a prior infection.
1874: 1834: 1699: 1644: 1254: 735: 427: 408: 354: 157: 1237:
Jason, LA; Brown AA; Clyne E; Bartgis L; Evans M; Brown M. (December 2011).
1662: 1635: 1595: 1515: 1479: 1460: 1416: 1325: 1272: 1171: 1000: 829: 786: 569: 114: 1550: 1167: 1116: 1080: 1046: 946: 618: 610: 557: 176: 170: 163: 56: 1776: 1528: 1288: 1216:"Myalgic Encephalomyelitis (ME). Criteria and clinical guidelines 2014" 1129: 759:
Jason LA, Corradi K, Torres-Harding S, Taylor RR, King C (March 2005).
605:
In addition to the CDC's recommendation, the NICE guideline recommends
598: 183: 48:
represent a variety of conditions rather than a single disease entity.
1746: 631: 614: 189: 1146: 407:
The London Criteria were designed for research purposes and used by
295:
And three physical criteria that must be documented by a physician:
1792: 1081:
Sharpe MC; Archard LC; Banatvala JE; et al. (February 1991).
1024: 561: 376:
At least one symptom from the lists for two of these categories:
758: 1441: 1394: 1384:. Centers of Disease Control and Prevention. 27 January 2021. 1292:"Myalgic encephalomyelitis: International Consensus Criteria" 1236: 1083:"A report--chronic fatigue syndrome: guidelines for research" 396: 196: 1442:
Reeves WC; Lloyd A; Vernon SD; et al. (December 2003).
710:"Long COVID: major findings, mechanisms and recommendations" 653: 1492: 1125:"Oxford criteria for the diagnosis of chronic fatigue syn" 923: 707: 40:(PEM) is required, and the number of symptoms needed. 807: 399:
i.e. Vitality, Social Functioning, and Role-Physical.
421:
Fluctuating symptoms, usually in response to exertion
1675: 1190:"London Criteria for M.E. – for website discussion" 877:. National Academy of Medicine. 2015. p. 210. 632:
Diagnostic complications and suggested improvements
434: 202:
post-exertional malaise lasting more than 24 hours.
1881:Myalgic encephalomyelitis/chronic fatigue syndrome 1748:Myalgic encephalomyelitis/chronic fatigue syndrome 1123: 613:tests, and mentions that blood tests for vitamins 353:The Canadian consensus criteria were initiated by 34:myalgic encephalomyelitis/chronic fatigue syndrome 1279: 761:"Chronic fatigue syndrome: the need for subtypes" 459:"Neurosensory, perceptual and motor disturbances" 129:of new or definite onset (has not been lifelong); 87:Also, at least one of the following is required: 1872: 1284: 1282: 1213: 279:Fatigue after exercise lasting at least 24 hours 25:Chart comparing the different definitions of CFS 901:. National Institutes of Health. Archived from 444:"Postexertional neuroimmune exhaustion" or PENE 1376: 1374: 899:"About CFS: What is Chronic Fatigue Syndrome?" 650:criteria include the use of severity ratings. 390:Symptoms must be present for at least 6 months 373:Two or more neurological or cognitive symptoms 348: 60:Chart from the CDC explaining the IOM criteria 1732: 1020: 1018: 256:Other fatiguing conditions must be eliminated 249:The Homes criteria require these two points: 479:Sensitivity to food, medicines, or chemicals 418:Impaired short-term memory and concentration 135:is not substantially alleviated by rest; and 1388: 1371: 979:Acta Neurologica Scandinavica. Supplementum 1739: 1725: 1015: 975:"The chronic fatigue syndrome – an update" 111:Centers for Disease Control and Prevention 1689: 1652: 1634: 1577: 1563: 1469: 1459: 1315: 1262: 1106: 1076: 1074: 990: 972: 776: 743: 725: 1187: 968: 966: 964: 939:10.7326/0003-4819-121-12-199412150-00009 364:"Post-Exertional Malaise and/or Fatigue" 214:The clinical evaluation should include: 55: 20: 1395:National Guideline Centre (UK) (2021). 1243:Evaluation & the Health Professions 1142: 1140: 891: 312: 1873: 1188:Shepherd, Charles (21 February 2011). 1071: 917: 512: 507:post-exertional neuroimmune exhaustion 291:A rapid onset over a few hours or days 132:is not the result of ongoing exertion; 77:Severe, disabling fatigue of new onset 1720: 1423:from the original on 19 February 2024 1348: 1346: 961: 1678:Journal of Disability Policy Studies 1137: 677: 675: 601:for blood cells, protein and glucose 241: 192:of a new type, pattern, or severity; 104: 64: 1214:Howes, S; Goudsmit, E; Shepard, C. 1156:Journal of Chronic Fatigue Syndrome 1147:Carruthers BM; et al. (2003). 528:Unrefreshing and/or disturbed sleep 13: 1343: 402: 186:without joint swelling or redness; 14: 1892: 801: 752: 672: 260:They define 11 symptom criteria: 1308:10.1111/j.1365-2796.2011.02428.x 992:10.1111/j.1600-0404.2007.00840.x 822:10.1097/00005053-200009000-00002 435:International Consensus Criteria 328:The fatigue must be debilitating 322:Fatigue must be the main symptom 226:A thorough physical examination; 1669: 1610: 1588:10.1016/j.biopsycho.2004.03.015 1557: 1522: 1508:10.1016/j.annepidem.2003.10.004 1486: 1435: 1332: 1230: 1207: 1181: 654:CDC "Empirical definition" 2005 30:Clinical descriptions of ME/CFS 16:Case definitions of the illness 1290:ML, Stevens S (October 2011). 862: 836: 701: 581:Erythrocyte sedimentation rate 325:There must be a definite onset 51: 1: 1860:Whittemore Peterson Institute 1543:10.1016/S0002-9343(96)90012-1 666: 470:Gets sick from viruses easily 415:Fatigue triggered by exercise 80:Post-exertional malaise (PEM) 1339:Australian Guidelines (2002) 276:Muscle discomfort or myalgia 169:tender cervical or axillary 152:self-reported impairment in 7: 1039:10.7326/0003-4819-108-3-387 714:Nature Reviews Microbiology 640: 624:, infectious diseases, and 496:Intolerance of heat or cold 397:Short Form 36 Health Survey 349:Canadian consensus criteria 10: 1897: 1099:10.1177/014107689108400224 727:10.1038/s41579-022-00846-2 538: 473:Gastro-intestinal symptoms 450:Neurocognitive impairments 1827: 1801: 1785: 1754: 778:10.1007/s11065-005-3588-2 661:Major Depressive Disorder 493:Temperature dysregulation 1850:Open Medicine Foundation 1700:10.1177/1044207308325995 1255:10.1177/0163278711424281 1065:29 November 2009 at the 302:Nonexudative pharyngitis 1855:Solve ME/CFS Initiative 1772:Post-exertional malaise 525:Post-exertional malaise 487:Cardiovascular symptoms 382:Neuroendocrine symptoms 288:Hypersomnia or insomnia 143:Additional requirements 95:Orthostatic intolerance 38:post-exertional malaise 1636:10.1186/1741-7015-3-19 1461:10.1186/1472-6963-3-25 576:Thyroid function tests 572:, and protein levels). 531:Cognitive difficulties 476:Genitourinary symptoms 61: 26: 1762:Clinical descriptions 1382:"Diagnosis of ME/CFS" 1168:10.1300/J092v11n01_02 626:adrenal insufficiency 59: 24: 1177:on 16 December 2008. 552:Complete blood count 522:Debilitating fatigue 490:Respiratory symptoms 313:Oxford 1991 criteria 264:Mild fever or chills 91:Cognitive impairment 1802:Society and history 1448:BMC Health Serv Res 905:on 16 February 2013 628:may be warranted. 513:National guidelines 83:Unrefreshing sleep. 45:pathology of ME/CFS 1194:The ME Association 973:Wyller VB (2007). 810:J. Nerv. Ment. Dis 689:. 19 November 2019 585:C-Reactive protein 379:Autonomic symptoms 305:Tender lymph nodes 236:multiple sclerosis 62: 27: 1868: 1867: 1408:978-1-4731-4221-3 884:978-0-309-31689-7 556:Blood chemistry ( 467:Flu-like symptoms 456:Sleep disturbance 367:Sleep dysfunction 242:CDC 1988 criteria 207:Final requirement 154:short-term memory 105:CDC 1994 criteria 65:2015 IOM criteria 1888: 1819:Notable patients 1741: 1734: 1727: 1718: 1717: 1712: 1711: 1693: 1673: 1667: 1666: 1656: 1638: 1614: 1608: 1607: 1581: 1561: 1555: 1554: 1526: 1520: 1519: 1490: 1484: 1483: 1473: 1463: 1439: 1433: 1432: 1430: 1428: 1392: 1386: 1385: 1378: 1369: 1368: 1366: 1364: 1350: 1341: 1336: 1330: 1329: 1319: 1286: 1277: 1276: 1266: 1234: 1228: 1227: 1226:on 14 July 2014. 1222:. Archived from 1211: 1205: 1204: 1202: 1200: 1185: 1179: 1178: 1176: 1170:. Archived from 1153: 1144: 1135: 1133: 1127: 1120: 1110: 1078: 1069: 1058: 1027:Ann. Intern. Med 1022: 1013: 1012: 994: 970: 959: 958: 921: 915: 914: 912: 910: 895: 889: 888: 876: 866: 860: 859: 857: 855: 840: 834: 833: 805: 799: 798: 780: 765:Neuropsychol Rev 756: 750: 749: 747: 729: 705: 699: 698: 696: 694: 679: 270:Sore lymph nodes 121:Primary symptoms 1896: 1895: 1891: 1890: 1889: 1887: 1886: 1885: 1871: 1870: 1869: 1864: 1823: 1797: 1781: 1750: 1745: 1715: 1691:10.1.1.508.1082 1674: 1670: 1615: 1611: 1579:10.1.1.595.4767 1562: 1558: 1527: 1523: 1491: 1487: 1440: 1436: 1426: 1424: 1409: 1393: 1389: 1380: 1379: 1372: 1362: 1360: 1358:www.nice.org.uk 1352: 1351: 1344: 1337: 1333: 1287: 1280: 1235: 1231: 1212: 1208: 1198: 1196: 1186: 1182: 1174: 1151: 1145: 1138: 1122: 1079: 1072: 1067:Wayback Machine 1023: 1016: 971: 962: 922: 918: 908: 906: 897: 896: 892: 885: 874: 868: 867: 863: 853: 851: 850:. 27 April 2021 842: 841: 837: 806: 802: 757: 753: 706: 702: 692: 690: 681: 680: 673: 669: 656: 643: 634: 622: 611:creatine kinase 541: 515: 437: 405: 403:London criteria 385:Immune symptoms 351: 315: 299:Low-grade fever 273:Muscle weakness 244: 107: 67: 54: 17: 12: 11: 5: 1894: 1884: 1883: 1866: 1865: 1863: 1862: 1857: 1852: 1847: 1845:ME Research UK 1842: 1840:ME Association 1837: 1831: 1829: 1825: 1824: 1822: 1821: 1816: 1811: 1805: 1803: 1799: 1798: 1796: 1795: 1789: 1787: 1783: 1782: 1780: 1779: 1774: 1769: 1764: 1758: 1756: 1755:Medical issues 1752: 1751: 1744: 1743: 1736: 1729: 1721: 1714: 1713: 1668: 1609: 1556: 1521: 1485: 1434: 1407: 1387: 1370: 1342: 1331: 1278: 1249:(3): 280–304. 1229: 1220:Axford's Abode 1206: 1180: 1136: 1070: 1014: 960: 933:(12): 953–59. 927:Ann Intern Med 916: 890: 883: 861: 835: 800: 751: 720:(3): 133–146. 700: 670: 668: 665: 655: 652: 642: 639: 633: 630: 620: 603: 602: 596: 593:Celiac disease 590: 587: 578: 573: 566:renal function 554: 540: 537: 533: 532: 529: 526: 523: 514: 511: 500: 499: 498: 497: 494: 491: 488: 482: 481: 480: 477: 474: 471: 468: 462: 461: 460: 457: 454: 451: 445: 436: 433: 423: 422: 419: 416: 404: 401: 392: 391: 388: 387: 386: 383: 380: 374: 371: 368: 365: 362: 361:Severe fatigue 350: 347: 339: 338: 335: 332: 329: 326: 323: 314: 311: 307: 306: 303: 300: 293: 292: 289: 286: 283: 280: 277: 274: 271: 268: 265: 258: 257: 254: 243: 240: 232: 231: 227: 224: 220: 209: 208: 204: 203: 200: 193: 187: 180: 174: 167: 161: 145: 144: 140: 139: 136: 133: 130: 123: 122: 106: 103: 98: 97: 92: 85: 84: 81: 78: 66: 63: 53: 50: 15: 9: 6: 4: 3: 2: 1893: 1882: 1879: 1878: 1876: 1861: 1858: 1856: 1853: 1851: 1848: 1846: 1843: 1841: 1838: 1836: 1835:Action for ME 1833: 1832: 1830: 1828:Organizations 1826: 1820: 1817: 1815: 1814:Controversies 1812: 1810: 1807: 1806: 1804: 1800: 1794: 1791: 1790: 1788: 1784: 1778: 1775: 1773: 1770: 1768: 1765: 1763: 1760: 1759: 1757: 1753: 1749: 1742: 1737: 1735: 1730: 1728: 1723: 1722: 1719: 1709: 1705: 1701: 1697: 1692: 1687: 1684:(2): 93–100. 1683: 1679: 1672: 1664: 1660: 1655: 1650: 1646: 1642: 1637: 1632: 1628: 1624: 1620: 1613: 1605: 1601: 1597: 1593: 1589: 1585: 1580: 1575: 1572:(2): 87–106. 1571: 1567: 1560: 1552: 1548: 1544: 1540: 1536: 1532: 1525: 1517: 1513: 1509: 1505: 1502:(2): 95–100. 1501: 1497: 1496:Ann Epidemiol 1489: 1481: 1477: 1472: 1467: 1462: 1457: 1453: 1449: 1445: 1438: 1422: 1418: 1414: 1410: 1404: 1400: 1399: 1391: 1383: 1377: 1375: 1359: 1355: 1349: 1347: 1340: 1335: 1327: 1323: 1318: 1313: 1309: 1305: 1302:(4): 327–38. 1301: 1297: 1293: 1285: 1283: 1274: 1270: 1265: 1260: 1256: 1252: 1248: 1244: 1240: 1233: 1225: 1221: 1217: 1210: 1195: 1191: 1184: 1173: 1169: 1165: 1161: 1157: 1150: 1143: 1141: 1131: 1126: 1118: 1114: 1109: 1104: 1100: 1096: 1093:(2): 118–21. 1092: 1088: 1084: 1077: 1075: 1068: 1064: 1061: 1056: 1052: 1048: 1044: 1040: 1036: 1033:(3): 387–89. 1032: 1028: 1021: 1019: 1010: 1006: 1002: 998: 993: 988: 984: 980: 976: 969: 967: 965: 956: 952: 948: 944: 940: 936: 932: 928: 920: 904: 900: 894: 886: 880: 873: 872: 865: 849: 845: 839: 831: 827: 823: 819: 816:(9): 568–76. 815: 811: 804: 796: 792: 788: 784: 779: 774: 770: 766: 762: 755: 746: 741: 737: 733: 728: 723: 719: 715: 711: 704: 688: 684: 678: 676: 671: 664: 662: 651: 647: 638: 629: 627: 623: 616: 612: 608: 600: 597: 594: 591: 588: 586: 582: 579: 577: 574: 571: 570:liver enzymes 567: 563: 559: 555: 553: 550: 549: 548: 544: 536: 530: 527: 524: 521: 520: 519: 510: 508: 503: 495: 492: 489: 486: 485: 483: 478: 475: 472: 469: 466: 465: 463: 458: 455: 452: 449: 448: 446: 443: 442: 441: 432: 429: 420: 417: 414: 413: 412: 410: 409:Action for ME 400: 398: 389: 384: 381: 378: 377: 375: 372: 369: 366: 363: 360: 359: 358: 356: 355:Health Canada 346: 342: 336: 333: 330: 327: 324: 321: 320: 319: 310: 304: 301: 298: 297: 296: 290: 287: 284: 281: 278: 275: 272: 269: 266: 263: 262: 261: 255: 252: 251: 250: 247: 239: 237: 228: 225: 221: 217: 216: 215: 212: 206: 205: 201: 198: 195:unrefreshing 194: 191: 188: 185: 181: 178: 175: 172: 168: 165: 162: 159: 158:concentration 155: 151: 150: 149: 142: 141: 137: 134: 131: 128: 127: 126: 120: 119: 118: 116: 112: 102: 96: 93: 90: 89: 88: 82: 79: 76: 75: 74: 72: 58: 49: 46: 41: 39: 35: 31: 23: 19: 1761: 1681: 1677: 1671: 1626: 1623:BMC Medicine 1622: 1612: 1569: 1566:Biol Psychol 1565: 1559: 1537:(1): 56–64. 1534: 1530: 1524: 1499: 1495: 1488: 1451: 1447: 1437: 1427:23 September 1425:. Retrieved 1397: 1390: 1361:. Retrieved 1357: 1334: 1299: 1296:J Intern Med 1295: 1246: 1242: 1232: 1224:the original 1219: 1209: 1197:. Retrieved 1193: 1183: 1172:the original 1159: 1155: 1121:Synopsis by 1090: 1086: 1030: 1026: 982: 978: 930: 926: 919: 907:. Retrieved 903:the original 893: 870: 864: 852:. Retrieved 847: 838: 813: 809: 803: 771:(1): 29–58. 768: 764: 754: 717: 713: 703: 691:. Retrieved 686: 657: 648: 644: 635: 604: 558:electrolytes 545: 542: 534: 516: 504: 501: 438: 424: 406: 393: 352: 343: 340: 316: 308: 294: 259: 248: 245: 233: 219:supplements; 213: 210: 146: 124: 115:Keiji Fukuda 108: 99: 86: 68: 42: 29: 28: 18: 1162:(1): 7–36. 1087:J R Soc Med 848:www.cdc.gov 687:www.cdc.gov 345:condition. 267:Sore throat 177:muscle pain 171:lymph nodes 164:sore throat 52:Definitions 1777:2-day CPET 1531:Am. J. Med 1130:GPnotebook 667:References 599:Urinalysis 589:Iron tests 583:(ESR) and 285:Joint pain 184:joint pain 1767:Treatment 1686:CiteSeerX 1645:1741-7015 1574:CiteSeerX 1454:(1): 25. 736:1740-1534 595:screening 282:Headaches 190:headaches 1875:Category 1793:DecodeME 1786:Research 1708:71852821 1663:16356178 1604:12601890 1596:15450690 1516:15018881 1480:14702202 1421:Archived 1417:35438857 1326:21777306 1273:22158691 1063:Archived 1055:42395288 1009:11247547 1001:17419822 985:: 7–14. 830:11009329 787:15929497 641:CDC 1994 1809:History 1654:1334212 1551:8579088 1317:3427890 1264:3658447 1117:1999813 1108:1293107 1060:Details 1047:2829679 947:7978722 909:27 June 795:8153255 745:9839201 562:glucose 539:Testing 370:Myalgia 1706:  1688:  1661:  1651:  1643:  1629:: 19. 1602:  1594:  1576:  1549:  1514:  1478:  1471:317472 1468:  1415:  1405:  1363:3 July 1324:  1314:  1271:  1261:  1199:4 July 1115:  1105:  1053:  1045:  1007:  999:  955:510735 953:  945:  881:  854:3 July 828:  793:  785:  742:  734:  693:3 July 428:Ramsay 182:multi- 1704:S2CID 1600:S2CID 1175:(PDF) 1152:(PDF) 1051:S2CID 1005:S2CID 951:S2CID 875:(PDF) 791:S2CID 607:HbA1c 197:sleep 1659:PMID 1641:ISSN 1592:PMID 1547:PMID 1512:PMID 1476:PMID 1429:2023 1413:PMID 1403:ISBN 1365:2022 1322:PMID 1269:PMID 1201:2022 1113:PMID 1043:PMID 997:PMID 943:PMID 911:2009 879:ISBN 856:2022 826:PMID 783:PMID 732:ISSN 695:2022 617:and 609:and 453:Pain 69:The 43:The 1696:doi 1649:PMC 1631:doi 1584:doi 1539:doi 1535:100 1504:doi 1466:PMC 1456:doi 1312:PMC 1304:doi 1300:270 1259:PMC 1251:doi 1164:doi 1103:PMC 1095:doi 1035:doi 1031:108 987:doi 983:187 935:doi 931:121 818:doi 814:188 773:doi 740:PMC 722:doi 156:or 71:IOM 1877:: 1702:. 1694:. 1682:20 1680:. 1657:. 1647:. 1639:. 1625:. 1621:. 1598:. 1590:. 1582:. 1570:68 1568:. 1545:. 1533:. 1510:. 1500:14 1498:. 1474:. 1464:. 1450:. 1446:. 1419:. 1411:. 1373:^ 1356:. 1345:^ 1320:. 1310:. 1298:. 1294:. 1281:^ 1267:. 1257:. 1247:35 1245:. 1241:. 1218:. 1192:. 1160:11 1158:. 1154:. 1139:^ 1128:. 1111:. 1101:. 1091:84 1089:. 1085:. 1073:^ 1049:. 1041:. 1029:. 1017:^ 1003:. 995:. 981:. 977:. 963:^ 949:. 941:. 929:. 846:. 824:. 812:. 789:. 781:. 769:15 767:. 763:. 738:. 730:. 718:21 716:. 712:. 685:. 674:^ 621:12 568:, 564:, 560:, 238:. 1740:e 1733:t 1726:v 1710:. 1698:: 1665:. 1633:: 1627:3 1606:. 1586:: 1553:. 1541:: 1518:. 1506:: 1482:. 1458:: 1452:3 1431:. 1367:. 1328:. 1306:: 1275:. 1253:: 1203:. 1166:: 1134:) 1132:. 1119:. 1097:: 1057:. 1037:: 1011:. 989:: 957:. 937:: 913:. 887:. 858:. 832:. 820:: 797:. 775:: 748:. 724:: 697:. 619:B 615:D 199:; 179:; 173:; 166:; 32:(

Index


myalgic encephalomyelitis/chronic fatigue syndrome
post-exertional malaise
pathology of ME/CFS

IOM
Orthostatic intolerance
Centers for Disease Control and Prevention
Keiji Fukuda
short-term memory
concentration
sore throat
lymph nodes
muscle pain
joint pain
headaches
sleep
multiple sclerosis
Health Canada
Short Form 36 Health Survey
Action for ME
Ramsay
post-exertional neuroimmune exhaustion
Complete blood count
electrolytes
glucose
renal function
liver enzymes
Thyroid function tests
Erythrocyte sedimentation rate

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.